Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1994-6-7
|
pubmed:abstractText |
The perioperative morbidity of local radical transurethral resection performed in 103 patients with muscle-invasive bladder cancer (T2-T3a) was 20%, their mortality 1%. The three- and five-year survivals were 54% and 36%, respectively. Within 5 years after transurethral resection of primary tumours relapses were encountered in 46%, progression in 33% of the cases. The cause of death was tumour in 29% of the patients, and some other disease in 35%. The full thickness transurethral resection combined with adjuvant treatment may be an alternative to cystectomy in selected cases of T2-T3a bladder cancer.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0301-1623
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
557-63
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8175277-Aged,
pubmed-meshheading:8175277-Combined Modality Therapy,
pubmed-meshheading:8175277-Female,
pubmed-meshheading:8175277-Follow-Up Studies,
pubmed-meshheading:8175277-Humans,
pubmed-meshheading:8175277-Male,
pubmed-meshheading:8175277-Muscles,
pubmed-meshheading:8175277-Neoplasm Invasiveness,
pubmed-meshheading:8175277-Neoplasm Recurrence, Local,
pubmed-meshheading:8175277-Neoplasm Staging,
pubmed-meshheading:8175277-Surgical Procedures, Operative,
pubmed-meshheading:8175277-Survival Rate,
pubmed-meshheading:8175277-Urethra,
pubmed-meshheading:8175277-Urinary Bladder Neoplasms
|
pubmed:year |
1993
|
pubmed:articleTitle |
Transurethral resection for muscle-invasive bladder cancer.
|
pubmed:affiliation |
Department of Urology, Municipal Péterffy Sándor Street Hospital, Budapest, Hungary.
|
pubmed:publicationType |
Journal Article
|